[HTML] mdpi.com

[HTML][HTML] Bone metabolism and RANKL/OPG ratio in rheumatoid arthritis women treated with TNF-α inhibitors

A Jura-Półtorak, A Szeremeta, K Olczyk… - Journal of clinical …, 2021 - mdpi.com
The aim of this study was to evaluate the effect of anti-tumor necrosis factor α (anti-TNF-α)
therapy in combination with methotrexate on bone remodeling and osteoclastogenesis in …
被引用次数：39 相关文章

Bone Metabolism and RANKL/OPG Ratio in Rheumatoid Arthritis Women Treated with TNF-α Inhibitors

A Jura-Półtorak, A Szeremeta, K Olczyk… - Journal of Clinical …, 2021 - search.proquest.com
The aim of this study was to evaluate the effect of anti-tumor necrosis factor α (anti-TNF-α)
therapy in combination with methotrexate on bone remodeling and osteoclastogenesis in …
[HTML] nih.gov

[HTML][HTML] Bone Metabolism and RANKL/OPG Ratio in Rheumatoid Arthritis Women Treated with TNF-α Inhibitors

A Jura-Półtorak, A Szeremeta, K Olczyk… - Journal of Clinical …, 2021 - ncbi.nlm.nih.gov
The aim of this study was to evaluate the effect of anti-tumor necrosis factor α (anti-TNF-α)
therapy in combination with methotrexate on bone remodeling and osteoclastogenesis in …

Bone Metabolism and RANKL/OPG Ratio in Rheumatoid Arthritis Women Treated with TNF-α Inhibitors.

A Jura-Półtorak, A Szeremeta, K Olczyk… - Journal of Clinical …, 2021 - europepmc.org
The aim of this study was to evaluate the effect of anti-tumor necrosis factor α (anti-TNF-α)
therapy in combination with methotrexate on bone remodeling and osteoclastogenesis in …

Bone Metabolism and RANKL/OPG Ratio in Rheumatoid Arthritis Women Treated with TNF-α Inhibitors.

A Jura-Półtorak, A Szeremeta… - Journal of Clinical …, 2021 - search.ebscohost.com
The aim of this study was to evaluate the effect of anti-tumor necrosis factor α (anti-TNF-α)
therapy in combination with methotrexate on bone remodeling and osteoclastogenesis in …
[PDF] semanticscholar.org

[PDF][PDF] Bone Metabolism and RANKL/OPG Ratio in Rheumatoid Arthritis Women Treated with TNF-α Inhibitors

A Jura-Półtorak, A Szeremeta, K Olczyk… - J. Clin …, 2021 - pdfs.semanticscholar.org
The aim of this study was to evaluate the effect of anti-tumor necrosis factor α (anti-TNF-α)
therapy in combination with methotrexate on bone remodeling and osteoclastogenesis in …

Bone Metabolism and RANKL/OPG Ratio in Rheumatoid Arthritis Women Treated with TNF-α Inhibitors

A Jura-Półtorak, A Szeremeta… - Journal of clinical …, 2021 - pubmed.ncbi.nlm.nih.gov
The aim of this study was to evaluate the effect of anti-tumor necrosis factor α (anti-TNF-α)
therapy in combination with methotrexate on bone remodeling and osteoclastogenesis in …
[PDF] mdpi.com

[PDF][PDF] Bone Metabolism and RANKL/OPG Ratio in Rheumatoid Arthritis Women Treated with TNF-α Inhibitors

A Jura-Półtorak, A Szeremeta, K Olczyk… - … and Therapy Effects in …, 2021 - mdpi.com
The aim of this study was to evaluate the effect of anti-tumor necrosis factor α (anti-TNF-α)
therapy in combination with methotrexate on bone remodeling and osteoclastogenesis in …